Interestingly, in neuroendocrine lung cancer, heterogeneous expression of Pax5 has been reported with the highest in the small cell (SCLC) subtype, followed by large cell and carcinoid(64). This evidence concerns the gene PAX5 and small cell lung carcinoma.